Phagos
Using bacteria's natural predator, the bacteriophage, we are able to overcome incurable and deadly infectious diseases.
Phagos has raised €27M across 2 funding rounds from 13 investors, most recently a Series A round in Oct 2025. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francephagos.org ↗
Total raised
€27M
€27,400,000
Funding rounds
2
Investors
13
distinct backers
Active since
2022-09
latest 2025-10
Funding by year
EUR raised per yearPhagos — funding by year — interactive chart.
Data table
| Phagos — funding by year | |
|---|---|
| 2022 | €2.4M |
| 2025 | €25M |
Signals
High confidenceRaise-next likelihood63
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood17
base rate 11% (2+ rounds)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-09 | Series A | €25M | Acurio Ventures,Capagro,CapHorn Invest,Citizen Capital,Demeter,Entrepreneurs First+3 more | View deal → |
| 2022-09-28 | Other | €2.4M | AgFunder,Entrepreneur First,Grant Aarons,Max Jamily | View deal → |
Investors
13Related news
- France’s Phagos raises €2.4m to replace antibiotics in animal farmssifted.eu · 2022-09
- tech.eu
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData